The expanding spectrum of thalassemia intermedia

Hematology

Volumn 14, Issue 6, 2009, Pages 311-314

  Panigrahi, Inusha ^a   Marwaha, Ram K ^a   Kulkarni, Ketan ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Alpha mutations; Genetic heterogeneity; Globin genes; Hemoglobin disorders; Somatic deletion; Splenomegaly

Indexed keywords

ALPHA GLOBIN; BETA GLOBIN; CCAAT ENHANCER BINDING PROTEIN; HEMOGLOBIN; HEMOGLOBIN ALPHA CHAIN;

BETA THALASSEMIA; DNA POLYMORPHISM; DNA SEQUENCE; GENE DELETION; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; INHERITANCE; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SOMATIC MUTATION; THALASSEMIA; THALASSEMIA INTERMEDIA;

ALPHA-GLOBINS; BETA-GLOBINS; GENE DELETION; HUMANS; PHENOTYPE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; THALASSEMIA;

EID: 71049121392     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/102453309X12473408860307     Document Type: Review

References (36)

1. Thein SL. β-Thalassemia. In: Higgs DR, Weatherall DJ. (eds) The haemoglobinopathies. Bailliere's Clin Haematol 1993; 6: 151-175.
2. Tamagnini GP, Lopes MC, Castanheira ME, Wainscoat JS. β+thalassemia Portuguese type: clinical, haematological and molecular studies of a newly defined form of β-thalassemia. Br J Haematol 1983; 54: 189-200.
3. Diaz-Chico JC, Yang KG, Stoming TA. Mild and severe bthalassemia among homozygotes from Turkey: identification of the types by hybridization of amplified DNA with synthetic probes. Blood 1988; 71: 248-253.
4. Rosatelli MC, Oggiano L, Leoni GB et al. Thalassemia intermedia resulting from a mild β-thalassemia mutation. Blood 1989; 73: 601-605.
5. Meloni A, Rosatelli MC, Faà V et al. Promoter mutations producing mild β-thalassemia in the Italian population. Br J Haematol 1992; 80: 222-226.
6. Adekile A, Haider M, Kutlar F. Mutations Associated with Beta-Thalassemia intermedia in Kuwait. Med Princ Pract 2005; 14: 69-72.
7. Neishabury M, Azarkeivan A, Oberkanins C, Esteghamat F, Amirizadeh N, Najmabadi H. Molecular mechanisms underlying thalassemia intermedia in Iran. Genetic Testing 2008; 12(4): 549-556.
8. Oner R, Oner C, Birben E, Sözen M, Gümrük F, Gü rgey A, Altay C. beta-Thalassaemia intermedia in a Turkish girl: homozygosity for G-->A substitution at +22 relative to the beta-globin cap site. Br J Haematol 2001; 115: 90-94.
9. Chen XW, Mo QH, Li Q, Zeng R, Xu XM. A novel mutation of -73(A-->T) in the CCAAT box of the beta-globin gene identified in a patient with the mild beta-thalassemia intermedia. Ann Hematol 2007; 86(9): 653-657.
10. Panigrahi I, Agarwal S, PradhanM, Choudhry DR, Choudhry VP, Saxena R. Molecular characterization of thalassemia intermedia in Indians. Haematologica 2006; 91: 1279-1280.
11. Nadkarni A, Gorakshakar AC, Lu CY, Krishnamoorthy R, Ghosh K, Colah R, Mohanty D 2001. Molecular pathogenesis and clinical variability of β-thalassemia syndromes among Indians. Am J Hematol 2001; 68: 75-80.
12. Tan Jin Ai MA, Yap SF, Tan KL, Wong YC, Wee YC, Kok JL. Mild beta-thalassemia intermedia caused by compound heterozygosity for (G)gamma((A)gammadeltabeta)(o)/beta-thalassemia and molecular characterization of the defect in four Chinese families. Acta Haematol 2003; 109: 169-175.
13. Karimi M, Yarmohammadi H, Farjadian S, Zeinali S, Moghaddam Z, Cappellini MD, Giordano PC. Beta-thalassemia intermedia from southern Iran: IVS-II-1 (G-->A) is the prevalent thalassemia intermedia allele. Hemoglobin 2002; 26: 147-154.
14. Haghi M, Feizi AA, Harteveld CL, Pouladi N, Feizi MA. Homozygosity for a rare beta 0-thalassemia mutation [frameshift codons 25/26 (+T)] causes beta-thalassemia intermedia in an Iranian family. Hemoglobin 2009; 33: 75-80.
15. Verma IC, Kleanthous M, Saxena R et al. Multicenter study of the molecular basis of thalassemia intermedia in different ethnic populations. Hemoglobin 2007; 31(4): 439-452.
16. Fucharoen S, Fucharoen G, Sanchaisuriya K, Surapot S. Molecular characterization of thalassemia intermedia associated with HPFH-6/beta- thalassemia and HPFH-6/Hb E in Thai patients. Acta Haematol 2002; 108(3): 157-161.
17. Fucharoen S, Pengjam Y, Surapot S, Fucharoen G, Sanchaisuriya K. Molecular and hematological characterization of HPFH-6/ Indian deletion-inversion Ggamma(Agammadeltabeta)0-thalassemia and Ggamma(Agammadeltabeta)0-thalassemia/HbE in Thai patients. Am J Hematol 2002; 71(2): 109-113.
18. Chang YP, Littera R, Garau R et al. The role of heterocellular hereditary persistence of fetal haemoglobin in beta(0)-thalassaemia intermedia. Br J Haematol 2001; 114(4): 899-906.
19. Qu G, Elkins S, Steinberg MH. Thalassemia intermedia and extramedullary hematopoiesis associated with compound heterozygosity for the 532 bp deletion of the beta-globin gene and gene deletion hereditary persistence of fetal hemoglobin. Hemoglobin 2001; 25(1): 91-96.
20. Li Z, Liu L, Zhao Y, Zhong X, Xu X. Two thalassemia intermedia patients with delta beta/beta thalassemia and a deletional type alpha-thalassemia. Haematologica 2001; 86(1): 108.
21. Shaji RV, Edison ES, Krishnamoorthy R, Chandy M, Srivastava A. Hb Lepore in the Indian population. Hemoglobin 2003; 27(1): 7-14.
22. So CC, Chan AY, Tsang ST et al. A novel beta-delta globin gene fusion, anti-Lepore Hong Kong, leads to overexpression of delta globin chain and a mild thalassaemia intermedia phenotype when co-inherited with beta(0)-thalassaemia. Br J Haematol 2007; 136: 158-162.
23. Camaschella C, Mazza U, Roetto A et al. Genetic interactions in thalassemia intermedia: analysis of beta-mutations, alpha-genotype, gamma-promoters, and beta-LCR hypersensitive sites 2 and 4 in Italian patients. Am J Hematol 1995; 48: 82-87.
24. Premawardhena A, Fisher CA, Olivieri NF et al. A novel molecular basis for beta thalassemia intermedia poses new questions about its pathophysiology. Blood 2005; 106(9): 3251-3255.
25. Efremov GD. Dominantly inherited beta-thalassemia. Hemoglobin 2007; 31(2): 193-207.
26. Faustino P, Osório-Almeida L, Romäo L et al. Dominantly transmitted beta-thalassemia arising from the production of several aberrant mRNA species and one abnormal peptide. Blood 1998; 91(2): 685-690.
27. Weinstein BI, Erramouspe B, Albuquerque DM et al. Hb Florida: a novel elongated C-terminal beta-globin variant causing dominant beta-thalassemia phenotype. Am J Hematol 2006; 81(5): 358-360.
28. Luo HY, Tang W, Eung SH et al. Dominantly inherited beta thalassaemia intermedia caused by a new single nucleotide deletion in exon 2 of the beta globin gene: Hb Morgantown (beta91 CTG>CG). J Clin Pathol 2005; 58(10): 1110-1112.
29. Gray GR, Manson HE, Gu LH, Leonova JYe, Huisman TH. Hb Lulu Island (alpha 2 beta 2 107[G9]Gly-->Asp)-beta zero thalassemia (codon 15; TGG-->TAG), a form of thalassemia intermedia. Am J Hematol 1995; 50(1): 26-29.
30. Badens C, Mattei MG, Imbert AM et al. A novel mechanism for thalassaemia intermedia. Lancet 2002; 12: 132-133.
31. Galanello R, Perseu L, Perra C et al. Somatic deletion of the normal beta-globin gene leading to thalassaemia intermedia in heterozygous beta-thalassaemic patients. Br J Haematol 2004; 127(5): 604-606.
32. Wajcman H, Traeger-Synodinos J, Papassotiriou I et al. Unstable and thalassemic alpha chain hemoglobin variants: a cause of Hb H disease and thalassemia intermedia. Hemoglobin 2008; 32(4): 327-349.
33. Fucharoen S, Fucharoen G, Sae-ung N, Sanchaisuriya K. Thalassemia intermedia associated with the Hb Constant Spring EE Bart's disease in pregnancy: a molecular and hematological analysis. Blood Cells Mol Dis 2007; 39(2): 195-198.
34. Stamoulakatou A, Athanasiou-Metaxa M, Traeger-Synodinos J et al. Rare thalassemic syndrome caused by interaction of Hb Questembert (alpha1 codon 131, TCT>CCT, Ser>Pro) with an alpha-thalassemia-2 deletion: implications for diagnosis and management. Blood Cells Mol Dis 2004; 32(1): 118-123.
35. Efremov GD, Simjanovska L, Plaseska-Karanfilska D, Stanojevic E, Petkov GH. Hb Jambol: a new hyperunstable hemoglobin causing severe hemolytic anemia. Acta Haematol 2007; 117: 1-7.
36. Sura T, Busabaratana M, Youngcharoen S, Wisedpanichkij R, Viprakasit V, Trachoo O. Haemoglobin Hope in a northern Thai family: first identification of homozygous haemoglobin Hope associated with haemoglobin H disease. Eur J Haematol 2007; 79: 251-254.